Related Articles
New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane
New aromatase inhibitors in the treatment of advanced breast cancer.
Current status and future potential role of exemestane in the treatment of early and advanced breast cancer (Review)
Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapy
Serum concentration of pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with metastatic breast cancer.